Has Milan Bajmoczi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $93,577 in general payments to Milan Bajmoczi, MD across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Milan Bajmoczi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Milan Bajmoczi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Milan Bajmoczi, MD

Vascular Surgery · Fairbanks, AKNPI 1700012598

Payments from drug & device makers

What this record shows

This record is dominated by other: $90,590 of the $93,577 with a category attached, or 96.8%. Angiodynamics, Inc. accounts for 96.9% of it on its own, with 11 other manufacturers making up the rest.

$93,577in general payments, 2019–2025

Across 51 payments — averaging $1834.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$91K
Abbott$2K
Philips North America LLC$115
Bard Peripheral Vascular, Inc.$82
W. L. Gore & Associates, Inc.$79
Getinge USA Sales, LLC$76
plus $179 from 6 others

What the payments were for

Travel & lodging$1,1201%
Food & beverage$1,8672%
Other$90,59097%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	7	$90,633
Abbott	21	$2,413
Philips North America LLC	2	$115
Bard Peripheral Vascular, Inc.	5	$82
W. L. Gore & Associates, Inc.	2	$79
Getinge USA Sales, LLC	4	$76
E.r. Squibb & Sons, L.L.C.	4	$63
Amgen	2	$46
Johnson & Johnson	1	$19
KCI USA, Inc.	1	$19
AstraZeneca	1	$18
Cook Medical LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular surgery providers in Alaskato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$570,288

Medicare patients

324

Services billed

1,882

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	67	$498

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Fairbanks

Jonathan McDonaghAnchorage$9K
Jonathan BarnesAnchorage$8K
Stanley WatkinsAnchorage$7K
Priya PatelAnchorage$6K
Galimat KhaidakovaAnchorage$5K
Seth KraussAnchorage$1K
April RodriguezAnchorage$997

See the full list for Alaska →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →